|
Symbol Name ID |
Slc10a2
solute carrier family 10, member 2 MGI:1201406 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Slc10a2tm1b(KOMP)Mbp/Slc10a2tm1b(KOMP)Mbp C57BL/6N-Slc10a2tm1b(KOMP)Mbp/Bay |
increased heart left ventricle size | J:211773 |
| Slc10a2tm1Pda/Slc10a2tm1Pda either: (involves: 129P2/OlaHsd * 129S6/SvEv) or (involves: 129P2/OlaHsd * C57BL/6J) |
abnormal bile composition | J:85312 |
| abnormal bile salt homeostasis | J:85312 | |
| abnormal bile salt level | J:85312 | |
| abnormal intestinal lipid absorption | J:85312 | |
| abnormal lipid homeostasis | J:85312 | |
| abnormal liver physiology | J:85312 | |
| decreased body weight | J:85312 | |
| decreased intestinal cholesterol absorption | J:85312 | |
| increased circulating cholesterol level | J:85312 | |
| increased feces bile salt level | J:85312 | |
| steatorrhea | J:85312 | |
| Slc10a2tm1Pda/Slc10a2tm1Pda either: B6.129P2-Slc10a2tm1Pda or (involves: 129P2/OlaHsd * C57BL/6J) |
abnormal bile salt homeostasis | J:132778 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/30/2025 MGI 6.24 |
|
|
|
||